Parallax Volatility Advisers’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.15M | Buy |
30,000
+15,100
| +101% | +$3.35M | 0.02% | 522 |
|
|
2025
Q4 | $3.4M | Sell |
14,900
-1,100
| -7% | -$251K | 0.01% | 788 |
|
|
2025
Q3 | $3.7M | Sell |
16,000
-46,700
| -74% | -$9.51M | 0.01% | 758 |
|
|
2025
Q2 | $11.6M | Sell |
62,700
-81,400
| -56% | -$15.1M | 0.03% | 388 |
|
|
2025
Q1 | $30.2M | Sell |
144,100
-533,000
| -79% | -$104M | 0.08% | 202 |
|
|
2024
Q4 | $120M | Buy |
677,100
+617,800
| +1,042% | +$114M | 0.23% | 73 |
|
|
2024
Q3 | $11.7M | Buy |
59,300
+32,600
| +122% | +$6.08M | 0.02% | 491 |
|
|
2024
Q2 | $4.58M | Sell |
26,700
-41,000
| -61% | -$6.79M | 0.01% | 746 |
|
|
2024
Q1 | $12.3M | Sell |
67,700
-82,900
| -55% | -$14.3M | 0.03% | 452 |
|
|
2023
Q4 | $23.3M | Buy |
150,600
+12,200
| +9% | +$1.78M | 0.05% | 349 |
|
|
2023
Q3 | $20.6M | Buy |
138,400
+21,800
| +19% | +$3.2M | 0.05% | 328 |
|
|
2023
Q2 | $15.7M | Buy |
116,600
+6,800
| +6% | +$997K | 0.03% | 409 |
|
|
2023
Q1 | $17.5M | Sell |
109,800
-54,100
| -33% | -$8.27M | 0.04% | 415 |
|
|
2022
Q4 | $26.5M | Sell |
163,900
-168,700
| -51% | -$25.9M | 0.04% | 438 |
|
|
2022
Q3 | $44.6M | Sell |
332,600
-26,800
| -7% | -$3.85M | 0.07% | 299 |
|
|
2022
Q2 | $55M | Sell |
359,400
-80,400
| -18% | -$12.3M | 0.05% | 253 |
|
|
2022
Q1 | $71.3M | Buy |
+439,800
| New | +$63.9M | 0.04% | 199 |
|
|
2020
Q4 | – | Sell |
-993,968
| Closed | -$87.1M | – | 2187 |
|
|
2020
Q3 | $87.1M | Sell |
993,968
-444,300
| -31% | -$41.8M | 0.06% | 258 |
|
|
2020
Q2 | $141M | Buy |
1,438,268
+928,168
| +182% | +$81.7M | 0.17% | 99 |
|
|
2020
Q1 | $38.9M | Sell |
510,100
-158,700
| -24% | -$13.5M | 0.05% | 244 |
|
|
2019
Q4 | $59.2M | Buy |
668,800
+453,200
| +210% | +$37.6M | 0.07% | 194 |
|
|
2019
Q3 | $16.3M | Sell |
215,600
-225,300
| -51% | -$15.4M | 0.02% | 460 |
|
|
2019
Q2 | $32.1M | Sell |
440,900
-254,100
| -37% | -$20M | 0.03% | 251 |
|
|
2019
Q1 | $56M | Buy |
695,000
+436,900
| +169% | +$35.7M | 0.06% | 146 |
|
|
2018
Q4 | $23.8M | Sell |
258,100
-155,900
| -38% | -$13.7M | 0.03% | 309 |
|
|
2018
Q3 | $39.2M | Buy |
414,000
+194,000
| +88% | +$18.4M | 0.05% | 173 |
|
|
2018
Q2 | $20.4M | Buy |
+220,000
| New | +$21.5M | 0.03% | 265 |
|
|
2018
Q1 | – | Sell |
-55,000
| Closed | -$5.32M | – | 2130 |
|
|
2017
Q4 | $5.32M | Buy |
55,000
+50,000
| +1,000% | +$4.71M | 0.01% | 585 |
|
|
2017
Q3 | $444K | Hold |
5,000
| – | – | ﹤0.01% | 1283 |
|
|
2017
Q2 | $363K | Sell |
5,000
-150,000
| -97% | -$10.1M | ﹤0.01% | 1308 |
|
|
2017
Q1 | $10.1M | Sell |
155,000
-36,500
| -19% | -$2.29M | 0.02% | 378 |
|
|
2016
Q4 | $12M | Buy |
191,500
+100,000
| +109% | +$6.1M | 0.02% | 397 |
|
|
2016
Q3 | $5.77M | Sell |
91,500
-3,653,900
| -98% | -$237M | 0.01% | 625 |
|
|
2016
Q2 | $232M | Buy |
+3,745,400
| New | +$228M | 0.46% | 26 |
|
|
2016
Q1 | – | Sell |
-124,800
| Closed | -$7.39M | – | 2411 |
|
|
2015
Q4 | $7.39M | Sell |
124,800
-131,700
| -51% | -$7.59M | 0.02% | 538 |
|
|
2015
Q3 | $14M | Buy |
256,500
+111,900
| +77% | +$7.28M | 0.03% | 333 |
|
|
2015
Q2 | $9.72M | Sell |
144,600
-22,700
| -14% | -$1.48M | 0.02% | 484 |
|
|
2015
Q1 | $9.79M | Hold |
167,300
| – | – | 0.02% | 473 |
|
|
2014
Q4 | $10.9M | Buy |
+167,300
| New | +$10.5M | 0.03% | 439 |
|
|
2014
Q1 | – | Sell |
-135,000
| Closed | -$7.13M | – | 3331 |
|
|
2013
Q4 | $7.13M | Buy |
+135,000
| New | +$6.64M | 0.03% | 356 |
|
Other funds holding ABBV
VCM
VPM
Parallax Volatility Advisers's ABBV Position: Q1 2026 in Review
Parallax Volatility Advisers increased its AbbVie (ABBV) stake by 124% in Q1 2026, buying an estimated $2.05M and bringing the position to 16,686 shares worth $3.42M. The position accounts for 0.01% of the portfolio, ranked #673.
Parallax Volatility Advisers first reported a position in ABBV in Q4 2013 and has held it in 32 quarters since. The position peaked at $23.4M in Q4 2018. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Parallax Volatility Advisers held 16,686 shares of AbbVie worth $3.42M as of Q1 2026.
- Parallax Volatility Advisers bought 9,251 AbbVie shares in Q1 2026, an estimated $2.05M.
- AbbVie made up 0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #673 holding.
- Parallax Volatility Advisers first reported a position in AbbVie in Q4 2013 and has held it in 32 quarters since.
- Parallax Volatility Advisers's AbbVie position peaked at $23.4M in Q4 2018.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.